Ji W - Search Results

1

The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.

Lu T, Li Z, Yang Y, Ji W, Yu Y, Niu X, Zeng Q, Xia W, Lu S. Lu T, et al. Among authors: ji w. Cancer Lett. 2018 Jun 1;423:36-46. doi: 10.1016/j.canlet.2018.02.015. Epub 2018 Feb 13. Cancer Lett. 2018. PMID: 29452146

2

FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.

Ji W, Yu Y, Li Z, Wang G, Li F, Xia W, Lu S. Ji W, et al. Oncotarget. 2016 Mar 22;7(12):15118-34. doi: 10.18632/oncotarget.7701. Oncotarget. 2016. PMID: 26936993 Free PMC article.

3

Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients.

Tan Q, Li F, Wang G, Xia W, Li Z, Niu X, Ji W, Yuan H, Xu Q, Luo Q, Zhang J, Lu S. Tan Q, et al. Among authors: ji w. Oncotarget. 2016 Apr 5;7(14):18394-402. doi: 10.18632/oncotarget.7817. Oncotarget. 2016. PMID: 26943773 Free PMC article.

4

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.

Yuan X, Ji W, Chen S, Bao Y, Tan S, Lu S, Wu K, Chu Q. Yuan X, et al. Among authors: ji w. Int J Nanomedicine. 2016 May 25;11:2119-31. doi: 10.2147/IJN.S92271. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27307727 Free PMC article.

5

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.

Yuan H, Li ZM, Shao J, Ji WX, Xia W, Lu S. Yuan H, et al. Among authors: ji wx. J Exp Clin Cancer Res. 2017 May 30;36(1):72. doi: 10.1186/s13046-017-0534-0. J Exp Clin Cancer Res. 2017. PMID: 28558758 Free PMC article.

6

Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].

Lu T, Li Z, Yang Y, Ji W, Yu Y, Niu X, Zeng Q, Xia W, Lu S. Lu T, et al. Among authors: ji w. Cancer Lett. 2018 Sep 1;431:244. doi: 10.1016/j.canlet.2018.04.014. Epub 2018 May 10. Cancer Lett. 2018. PMID: 29754994 No abstract available.

7

FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.

Wang K, Ji W, Yu Y, Li Z, Niu X, Xia W, Lu S. Wang K, et al. Among authors: ji w. Oncogene. 2018 Sep;37(39):5340-5354. doi: 10.1038/s41388-018-0311-3. Epub 2018 Jun 1. Oncogene. 2018. PMID: 29858603

8

Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.

He S, Li Z, Yu Y, Zeng Q, Cheng Y, Ji W, Xia W, Lu S. He S, et al. Among authors: ji w. Exp Cell Res. 2019 Jun 15;379(2):203-213. doi: 10.1016/j.yexcr.2019.03.035. Epub 2019 Apr 10. Exp Cell Res. 2019. PMID: 30978341

9

Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer.

Yang Y, Li Z, Yuan H, Ji W, Wang K, Lu T, Yu Y, Zeng Q, Li F, Xia W, Lu S. Yang Y, et al. Among authors: ji w. Oncogenesis. 2019 Sep 6;8(9):50. doi: 10.1038/s41389-019-0151-1. Oncogenesis. 2019. PMID: 31492847 Free PMC article.

10

βKlotho is identified as a target for theranostics in non-small cell lung cancer.

Li F, Li X, Li Z, Ji W, Lu S, Xia W. Li F, et al. Among authors: ji w. Theranostics. 2019 Oct 12;9(25):7474-7489. doi: 10.7150/thno.35582. eCollection 2019. Theranostics. 2019. PMID: 31695781 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,356 results

Search Page

Filters